Smart Meter Announces Expansion Of Their Remote Patient Monitoring (RPM) Portfolio With The Launch Of iBloodPressure® Cellular Connected Blood Pressure Monitor

Smart Meter providers can now offer additional RPM services to over 100M hypertensive patients, driving better outcomes through real-time data

Tampa, FL (PRWEB) - Smart Meter announced today the launch of the iBloodPressure® Cellular Connected Blood Pressure Monitor. The home-use iBloodPressure Monitor is the only monitor with AutoShare™, a 4/5G LTE communication chip allowing all patient results to be transmitted automatically to RPM portals without the need for syncing, apps, smartphones, WiFi, or docking stations. Uniquely, the built-in enhanced CAT-M technology provides better building penetration reducing interruptions, providing more robust connections for real-time RPM and better clinical efficiencies. More impactful connected care between visits is possible with this technology which sends data and messages directly to the cloud, to patients, caregivers, and clinicians as soon as a patient tests. Patients only need to test, and Smart Meter does the rest.

“Our user base has grown nearly ten-fold, a testament to the fact that Smart Meter makes it easy for healthcare providers, patients and organizations to implement and scale sustainable RPM programs in a matter of weeks, supporting patient populations of all sizes,” says Smart Meter CEO Brahim Zabeli. “Our cellular-enabled iBloodPressure Monitor and iGlucose® Blood Glucose Meter do not require patient setup. Rapid on-boarding and instant transmission of data fulfills CPT® requirements for efficient reimbursement.”

Smart Meter products provide secure, consistent, and accurate data enabling a higher level of patient care and potential to improve outcomes.

“RPM evolved as a rapidly adopted mode of care delivery in 2020, of which Smart Meter has been an integral part in bridging the historic in-person care setting. The addition of the new cellular-enabled iBloodPressure cuff to its digital offerings will complement a growing suite of cellular monitoring devices enabling chronic care disease management. The simplicity of activation, monitoring and utilization of these devices partially circumvents many of the health care access hurdles of digital literacy for the elderly. For clinical care organizations, their job just became easier. Smart Meter’s suite of products now enables RPM to improve clinical and medication adherence as well as endpoint clinical outcome measurements like A1c and HBP,” according to Bill Lewis, MD and Principal at WellMedcare. “These devices should be part of any RPM program.”

For more information or a product demonstration, please contact Smart Meter at 813-773-4080 or e-mail: support@iglucose.com

About Smart Meter, LLC
Smart Meter, LLC is a rapidly growing end-to-end solutions provider to businesses in the fast-growing telehealth and remote patient monitoring markets. Smart Meter’s cellular-connected medical devices, data transmission, and digital portals offer significant ease of use and cost advantages. The iGlucose system has quickly become the platform of choice among emerging remote care companies, telehealth providers and long-term care facilities during COVID-19. Their patented devices transmit real-time results to a HIPPA-compliant cloud portal that provides trends, alerts, and formatted billing information. Unlike devices requiring the use of smartphones, apps, Bluetooth, cables, WiFi, or docking stations, iGlucose and iBloodPressure seamlessly and automatically transmit information with no user interaction.